Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?

Veluswamy S, Shah P, Denton CC, Chalacheva P, Khoo MCK, Coates TD.

J Clin Med. 2019 Oct 15;8(10). pii: E1690. doi: 10.3390/jcm8101690. Review.

2.

Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES.

Ann Am Thorac Soc. 2019 Sep;16(9):e17-e32. doi: 10.1513/AnnalsATS.201906-433ST.

PMID:
31469310
3.

Shared Care for Adults with Sickle Cell Disease: An Analysis of Care from Eight Health Systems.

Mainous AG 3rd, Rooks B, Tanner RJ, Carek PJ, Black V, Coates TD.

J Clin Med. 2019 Aug 2;8(8). pii: E1154. doi: 10.3390/jcm8081154.

4.

Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.

Detterich JA, Liu H, Suriany S, Kato RM, Chalacheva P, Tedla B, Shah PM, Khoo MC, Wood JC, Coates TD, Milne GL, Oh JY, Patel RP, Forman HJ.

Free Radic Biol Med. 2019 Sep;141:408-415. doi: 10.1016/j.freeradbiomed.2019.07.004. Epub 2019 Jul 3.

PMID:
31279092
5.

Anemia predicts lower white matter volume and cognitive performance in sickle and non-sickle cell anemia syndrome.

Choi S, O'Neil SH, Joshi AA, Li J, Bush AM, Coates TD, Leahy RM, Wood JC.

Am J Hematol. 2019 Oct;94(10):1055-1065. doi: 10.1002/ajh.25570. Epub 2019 Jul 23.

PMID:
31259431
6.

Sickle Cell Disease Subjects Have a Distinct Abnormal Autonomic Phenotype Characterized by Peripheral Vasoconstriction With Blunted Cardiac Response to Head-Up Tilt.

Chalacheva P, Kato RM, Shah P, Veluswamy S, Denton CC, Sunwoo J, Thuptimdang W, Wood JC, Detterich JA, Coates TD, Khoo MCK.

Front Physiol. 2019 Apr 11;10:381. doi: 10.3389/fphys.2019.00381. eCollection 2019.

7.

Mental stress causes vasoconstriction in sickle cell disease and normal controls.

Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, Kato RM, Detterich J, Wood JC, Zeltzer L, Sposto R, Khoo MCK, Coates TD.

Haematologica. 2019 Apr 11. pii: haematol.2018.211391. doi: 10.3324/haematol.2018.211391. [Epub ahead of print]

8.

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.

Rogers ZR, Nakano TA, Olson TS, Bertuch AA, Wang W, Gillio A, Coates TD, Chawla A, Castillo P, Kurre P, Gamper C, Bennett CM, Joshi S, Geddis AE, Boklan J, Nalepa G, Rothman JA, Huang JN, Kupfer GM, Cada M, Glader B, Walkovich KJ, Thompson AA, Hanna R, Vlachos A, Malsch M, Weller EA, Williams DA, Shimamura A.

Haematologica. 2019 Oct;104(10):1974-1983. doi: 10.3324/haematol.2018.206540. Epub 2019 Apr 4.

9.

Sickle cell microvascular paradox-oxygen supply-demand mismatch.

Detterich JA, Kato R, Bush A, Chalacheva P, Ponce D, De Zoysa M, Shah P, Khoo MC, Meiselman HJ, Coates TD, Wood JC.

Am J Hematol. 2019 Jun;94(6):678-688. doi: 10.1002/ajh.25476. Epub 2019 Apr 19.

PMID:
30916797
10.

Introduction to a review series on human neutrophils.

Berliner N, Coates TD.

Blood. 2019 May 16;133(20):2111-2112. doi: 10.1182/blood-2019-01-891770. Epub 2019 Mar 21. No abstract available.

PMID:
30898861
11.

White matter has impaired resting oxygen delivery in sickle cell patients.

Chai Y, Bush AM, Coloigner J, Nederveen AJ, Tamrazi B, Vu C, Choi S, Coates TD, Lepore N, Wood JC.

Am J Hematol. 2019 Apr;94(4):467-474. doi: 10.1002/ajh.25423. Epub 2019 Feb 21.

PMID:
30697803
12.

Patients with sickle-cell disease exhibit greater functional connectivity and centrality in the locus coeruleus compared to anemic controls.

Bhatt RR, Zeltzer LK, Coloigner J, Wood JC, Coates TD, Labus JS.

Neuroimage Clin. 2019;21:101686. doi: 10.1016/j.nicl.2019.101686. Epub 2019 Jan 22. No abstract available.

13.

Introduction to a review series on iron metabolism and its disorders.

Coates TD, Cazzola M.

Blood. 2019 Jan 3;133(1):1-2. doi: 10.1182/blood-2018-10-876466. Epub 2018 Nov 14. No abstract available.

PMID:
30429162
14.

ORCHESTRAL FULLY CONVOLUTIONAL NETWORKS FOR SMALL LESION SEGMENTATION IN BRAIN MRI.

Xu B, Chai Y, Galarza CM, Vu CQ, Tamrazi B, Gaonkar B, Macyszyn L, Coates TD, Lepore N, Wood JC.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:889-892. doi: 10.1109/ISBI.2018.8363714. Epub 2018 May 24.

15.

A novel cross-correlation methodology for assessing biophysical responses associated with pain.

Sunwoo J, Chalacheva P, Khaleel M, Shah P, Sposto R, Kato RM, Detterich J, Zeltzer LK, Wood JC, Coates TD, Khoo MC.

J Pain Res. 2018 Oct 5;11:2207-2219. doi: 10.2147/JPR.S142582. eCollection 2018.

16.

Introduction to a How I Treat series on sickle cell disease and thalassemia.

Coates TD.

Blood. 2018 Oct 25;132(17):1729-1730. doi: 10.1182/blood-2018-08-858118. Epub 2018 Sep 11. No abstract available.

PMID:
30206114
17.

Effectiveness of Clinical Decision Support Based Intervention in the Improvement of Care for Adult Sickle Cell Disease Patients in Primary Care.

Mainous AG 3rd, Carek PJ, Lynch K, Tanner RJ, Hulihan MM, Baskin J, Coates TD.

J Am Board Fam Med. 2018 Sep-Oct;31(5):812-816. doi: 10.3122/jabfm.2018.05.180106.

18.

Increased brain iron deposition in patients with sickle cell disease: an MRI quantitative susceptibility mapping study.

Miao X, Choi S, Tamrazi B, Chai Y, Vu C, Coates TD, Wood JC.

Blood. 2018 Oct 11;132(15):1618-1621. doi: 10.1182/blood-2018-04-840322. Epub 2018 Jul 25. No abstract available.

19.

Autonomic nervous system involvement in sickle cell disease.

Coates TD, Chalacheva P, Zeltzer L, Khoo MCK.

Clin Hemorheol Microcirc. 2018;68(2-3):251-262. doi: 10.3233/CH-189011.

PMID:
29614636
20.

You don't always get what you want: Does hypoxia cause sickle cell crisis?

Coates TD.

Am J Hematol. 2018 Aug;93(4):475-477. doi: 10.1002/ajh.25048. No abstract available.

21.

Diminished cerebral oxygen extraction and metabolic rate in sickle cell disease using T2 relaxation under spin tagging MRI.

Bush AM, Coates TD, Wood JC.

Magn Reson Med. 2018 Jul;80(1):294-303. doi: 10.1002/mrm.27015. Epub 2017 Dec 1.

22.

Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia.

Coloigner J, Kim Y, Bush A, Choi S, Balderrama MC, Coates TD, O'Neil SH, Lepore N, Wood JC.

PLoS One. 2017 Oct 5;12(10):e0184860. doi: 10.1371/journal.pone.0184860. eCollection 2017.

23.

The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: a pilot study.

Bhatt RR, Martin SR, Evans S, Lung K, Coates TD, Zeltzer LK, Tsao JC.

J Pain Res. 2017 Jul 14;10:1635-1644. doi: 10.2147/JPR.S131859. eCollection 2017.

24.

Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease.

Coloigner J, Phlypo R, Coates TD, Lepore N, Wood JC.

Brain Connect. 2017 Sep;7(7):443-453. doi: 10.1089/brain.2016.0474.

25.

Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Khaleel M, Puliyel M, Shah P, Sunwoo J, Kato RM, Chalacheva P, Thuptimdang W, Detterich J, Wood JC, Tsao J, Zeltzer L, Sposto R, Khoo MCK, Coates TD.

Am J Hematol. 2017 Nov;92(11):1137-1145. doi: 10.1002/ajh.24858. Epub 2017 Aug 17.

26.

Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease.

Chalacheva P, Khaleel M, Sunwoo J, Shah P, Detterich JA, Kato RM, Thuptimdang W, Meiselman HJ, Sposto R, Tsao J, Wood JC, Zeltzer L, Coates TD, Khoo MCK.

PLoS One. 2017 May 24;12(5):e0178353. doi: 10.1371/journal.pone.0178353. eCollection 2017.

27.

Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.

Choi S, Bush AM, Borzage MT, Joshi AA, Mack WJ, Coates TD, Leahy RM, Wood JC.

Neuroimage Clin. 2017 Apr 29;15:239-246. doi: 10.1016/j.nicl.2017.04.023. eCollection 2017.

28.

The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.

Gomperts E, Belcher JD, Otterbein LE, Coates TD, Wood J, Skolnick BE, Levy H, Vercellotti GM.

Am J Hematol. 2017 Jun;92(6):569-582. doi: 10.1002/ajh.24750. Epub 2017 Apr 29. Review.

29.

How we manage iron overload in sickle cell patients.

Coates TD, Wood JC.

Br J Haematol. 2017 Jun;177(5):703-716. doi: 10.1111/bjh.14575. Epub 2017 Mar 14. Review.

30.

Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.

Angelucci E, Pilo F, Coates TD.

Am J Hematol. 2017 May;92(5):411-413. doi: 10.1002/ajh.24674. Epub 2017 Mar 22. No abstract available.

31.

Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26390. Epub 2016 Dec 21.

32.

Unchanneling cardiac iron in humans.

Coates TD.

Blood. 2016 Sep 22;128(12):1538-40. doi: 10.1182/blood-2016-07-729475. No abstract available.

PMID:
27658696
33.

Determinants of resting cerebral blood flow in sickle cell disease.

Bush AM, Borzage MT, Choi S, Václavů L, Tamrazi B, Nederveen AJ, Coates TD, Wood JC.

Am J Hematol. 2016 Sep;91(9):912-7. doi: 10.1002/ajh.24441. Epub 2016 Jul 4.

34.

Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?

Coates TD, Carson S, Wood JC, Berdoukas V.

Ann N Y Acad Sci. 2016 Mar;1368(1):95-106. doi: 10.1111/nyas.13060. Review.

PMID:
27186942
35.

Predictors of cerebral blood flow in patients with and without anemia.

Borzage MT, Bush AM, Choi S, Nederveen AJ, Václavů L, Coates TD, Wood JC.

J Appl Physiol (1985). 2016 Apr 15;120(8):976-81. doi: 10.1152/japplphysiol.00994.2015. Epub 2016 Jan 21.

36.

Early Cardiac Iron Overload in a Child on Treatment of Acute Lymphoblastic Leukemia.

Reitman AJ, Coates TD, Freyer DR.

Pediatrics. 2015 Sep;136(3):e697-700. doi: 10.1542/peds.2014-3770. Epub 2015 Aug 17.

37.

Iron and oxidative stress in cardiomyopathy in thalassemia.

Berdoukas V, Coates TD, Cabantchik ZI.

Free Radic Biol Med. 2015 Nov;88(Pt A):3-9. doi: 10.1016/j.freeradbiomed.2015.07.019. Epub 2015 Jul 26. Review.

PMID:
26216855
38.

Autonomic responses to cold face stimulation in sickle cell disease: a time-varying model analysis.

Chalacheva P, Kato RM, Sangkatumvong S, Detterich J, Bush A, Wood JC, Meiselman H, Coates TD, Khoo MC.

Physiol Rep. 2015 Jul 14;3(7). pii: e12463. doi: 10.14814/phy2.12463. Epub 2015 Jul 14.

39.

Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.

Detterich JA, Kato RM, Rabai M, Meiselman HJ, Coates TD, Wood JC.

Blood. 2015 Aug 6;126(6):703-10. doi: 10.1182/blood-2014-12-614370. Epub 2015 Jun 2.

40.

Prediabetes, elevated iron and all-cause mortality: a cohort study.

Mainous AG 3rd, Tanner RJ, Coates TD, Baker R.

BMJ Open. 2014 Dec 11;4(12):e006491. doi: 10.1136/bmjopen-2014-006491.

41.

Pulmonary hypertension in well-transfused thalassemia major patients.

Meloni A, Detterich J, Pepe A, Harmatz P, Coates TD, Wood JC.

Blood Cells Mol Dis. 2015 Feb;54(2):189-94. doi: 10.1016/j.bcmd.2014.11.003. Epub 2014 Nov 24.

42.

Iron toxicity and its possible association with treatment of Cancer: lessons from hemoglobinopathies and rare, transfusion-dependent anemias.

Puliyel M, Mainous AG 3rd, Berdoukas V, Coates TD.

Free Radic Biol Med. 2015 Feb;79:343-51. doi: 10.1016/j.freeradbiomed.2014.10.861. Epub 2014 Nov 14. Review.

PMID:
25463277
43.

Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).

Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB.

Pediatr Blood Cancer. 2014 Dec;61(12):2271-6. doi: 10.1002/pbc.25208. Epub 2014 Aug 30.

PMID:
25176145
44.

The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome.

Mainous AG 3rd, Tanner RJ, Hulihan MM, Amaya M, Coates TD.

Br J Haematol. 2014 Dec;167(5):720-3. doi: 10.1111/bjh.13053. Epub 2014 Jul 22. Review. No abstract available.

45.

A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing.

Huang KE, Mittelman SD, Coates TD, Geffner ME, Wood JC.

J Pediatr Hematol Oncol. 2015 Jan;37(1):54-9. doi: 10.1097/MPH.0000000000000199.

46.

Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Coates TD.

Free Radic Biol Med. 2014 Jul;72:23-40. doi: 10.1016/j.freeradbiomed.2014.03.039. Epub 2014 Apr 12. Review.

47.

Cardiac iron overload in sickle-cell disease.

Meloni A, Puliyel M, Pepe A, Berdoukas V, Coates TD, Wood JC.

Am J Hematol. 2014 Jul;89(7):678-83. doi: 10.1002/ajh.23721. Epub 2014 Apr 15.

48.

Bad liver and a broken heart.

Coates TD.

Blood. 2014 Mar 6;123(10):1434-6. doi: 10.1182/blood-2014-01-548552.

PMID:
24627546
49.

Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.

Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD.

Am J Hematol. 2014 Apr;89(4):391-4. doi: 10.1002/ajh.23650. Epub 2014 Feb 28.

50.

β-globin gene transfer to human bone marrow for sickle cell disease.

Romero Z, Urbinati F, Geiger S, Cooper AR, Wherley J, Kaufman ML, Hollis RP, de Assin RR, Senadheera S, Sahagian A, Jin X, Gellis A, Wang X, Gjertson D, Deoliveira S, Kempert P, Shupien S, Abdel-Azim H, Walters MC, Meiselman HJ, Wenby RB, Gruber T, Marder V, Coates TD, Kohn DB.

J Clin Invest. 2013 Jul 1. pii: 67930. doi: 10.1172/JCI67930. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center